Cutting edge: Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2267-2271

  Bandeira Melo, Christianne ^a   Bozza, Patricia T ^a   Diaz, Bruno L ^a   Cordeiro, Renato S B ^a   Jose, Peter J ^b   Martins, Marco A ^a   Serhan, Charles N ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; ALUMINUM HYDROXIDE; EOTAXIN; HISTAMINE; INTERLEUKIN 5; LIPOXIN A; OVALBUMIN; THROMBOCYTE ACTIVATING FACTOR;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; LEUKOCYTE MIGRATION INHIBITION; LUNG EDEMA; MALE; MAST CELL DEGRANULATION; NEUTROPHILIA; NONHUMAN; PLEURISY; PRIORITY JOURNAL; RAT;

EID: 0034163279     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2267     Document Type: Article

References (36)

1. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of eosinophilic leukocyte. Annu. Rev. Med. 44:85.
2. Weller, P. F. 1997. Human eosinophils. J. Allergy Clin. Immunol. 100:283.
3. Rothenberg, M. E. 1998. Eosinophilia. N. Engl. J. Med. 28:1592.
4. Barnes, P. J. 1995. Drug therapy: inhaled glucocorticoids for asthma. N. Engl. J. Med. 332: 868.
5. Wolthers, O. D. 1996. Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids. Eur. Resp. J. 9:821.
6. Serhan, C. N. 1997. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 53:107.
7. Serhan, C. N., T. Takano, and J. F. Maddox. 1999. Aspirin-triggered 15-epilipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation: receptors and pathways. In Lipoxygenases and Their Metabolites. Nigam and Pace-Asciak, eds. Plenum Press, New York, p. 133.
8. Lee, T. H., A. E. Crea, V. Gant, B. W. Spur, B. E. Marron, K. C. Nicolaou, E. Reardon, M. Brezinski, and C. N. Serhan. 1990. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am. Rev. Respir. Dis. 141:1453.
9. Edenius, C., M. Kumlin, T. Bjork, A. Anggard, and J. A. Lindgren. 1990. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett. 272:25.
10. Levy, B. D., S. Bertram, H. H. Tai E. Israel, A. Fischer, J. M. Drazen, and C. N. Serhan. 1993. Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. Lipids 28:1047.
11. Levy, B. D., J. M. Drazen, and C. N. Serhan. 1997. Agonist-induced lipoxin A4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA. Adv. Exp. Med. Biol. 400B:611.
12. Serhan, C. N., U. Hirsch, J. Palmblad, and B. Samuelsson. 1987. Formation of lipoxin A by granulocytes from eosinophilic donors. FEBS Lett. 217:242.
13. Soyombo, O., B. W. Spur, and T. H. Lee 1994. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Allergy 49:230.
14. Gornall, A. G., C.J. Bardawill, and MM. David. 1949. Determination of serum protein by means of the biuret reaction. J. Biol. Chem., 177:751.
15. Diaz, B. L., A. C. Alves, A. L. Pires, F. M. Correa, R. S. Cordeiro, M. A. Martins, and P. M. Silva. 1996. Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats. Int. Arch. Allergy Immunol. 111:36.
16. Alves, A. C., A. L. Pires, H. N. Cruz, M. F. Serra, B. L. Diaz, R. S. Cordeiro, V. Lagente, and M. A. Martins. 1996. Selective inhibition of phosphodiesterase type IV suppresses the chemotactic responsiveness of rat eosinophils in vitro. Eur. J. Pharmacol. 312:89.
17. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440.
18. Sanderson, C. J. 1992. Interleukin-5, eosinophils and disease. Blood 79:3101.
19. Luster, A. D., and M. E. Rothenberg. 1997. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukocyte Biol. 62:620.
20. Pasquale, C. P., M. C. Lima, C. Bandeira-Melo, R. S. Cordeiro, P. M. Silva, and M. A. Martins. 1999. Systemic and local dexamethasone treatments prevent allergic eosinophilia in rats via distinct mechanisms. Eur. J. Pharmacol. 26:67.
21. Clish, C. B., J. A. O'Brien, K. Gronert, G. L. Stahl, N. A. Petasis and C. N. Serhan. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96:8247.
22. Serhan, C. N., J. F. Maddox, N. A. Petasis, I. Akritopoulou-Zanze, A. Papayianni, R. Brady, S. P. Colgan, and J. L. Madara. 1995. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 7:14609.
23. Takano, T., S. Fiore, J. F. Maddox, H. R. Brady, N. A. Petasis, and C. N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.
24. Takano, T., C. B. Clish, K. Gronert, N. Petasis, and C. N. Serhan. 1998. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J. Clin. Invest. 101:819.
25. Lee, T. H., C. E. Horton, U. Kyan-Aung, D. Haskard, A. E. Crea, and B. W. Spur. 1989. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin. Sci. 77:195.
26. Colgan, S. P., C. N. Serhan, C. A. Parkos, C. Delp-Archer, and J. L. Madara. 1993. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J. Clin. Invest. 92:72.
27. Papayianni, A., C. N. Serhan, and H. R Brady. 1996. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156:2264.
28. Gewirtz, A. T., V. V. Fokin, N. A. Petasis, C. N. Serhan, and J. L. Madara. 1999. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am. J. Physiol. 276:C988.
29. Hachicha, M., M. Pouliot, N. A. Petasis, and C. N. Serhan. 1999. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1α-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189:1923.
30. 2 integrin-dependent eosinophil accumulation in ral skin in vivo: delayed generation of eotaxin in response to IL-4. J. Immunol. 160:3569.
31. Gronert, K., A. Gewirtz, J. L. Madara, and C. N. Serhan. 1998. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon γ and inhibits tumor necrosis factor α-induced 1L-8 release. J. Exp. Med. 187:1285.
32. Gewirtz, A. T., B. McCormick, A. S. Neish, N. A. Petasis, K. Gronert, C. N. Serhan, and J. L. Madara. 1998. Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. J. Clin. Invest. 101:1860.
33. Silva, P. M., M. A. Martins, R. S. Cordeiro, and B. B. Vargaftig. 1989. Late eosinophil mobilization induced by PAF-acether in the pleural cavity of rats. Braz. J Med. Biol. Res. 22:1281.
34. Martins, M. A., P. M. Silva, H. C. Faria Neto, P. T. Bozza, P. M. Dias, M. C. Lima, R. S. Cordeiro, and B. B. Vargaftig. 1989. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan. Br. J. Pharmacol. 96:363.
35. Silva, P. M., M. A. Martins, M. C. Lima, A. C. Alves, B. L. Diaz, and R. S. B. Cordeiro. 1992. Pharmacological modulation of the late eosinophilia induced by antigen in actively sensitized rats. Int. Arch. Allergy Immunol. 98:355.
36. Christie, P. E. B. W. Spur, and T. H. Lee. 1992. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am. Rev. Respir. Dis. 145:1281.